CA1058075A - Procede pour ameliorer la compatibilite des gamma globulines - Google Patents

Procede pour ameliorer la compatibilite des gamma globulines

Info

Publication number
CA1058075A
CA1058075A CA242,734A CA242734A CA1058075A CA 1058075 A CA1058075 A CA 1058075A CA 242734 A CA242734 A CA 242734A CA 1058075 A CA1058075 A CA 1058075A
Authority
CA
Canada
Prior art keywords
gamma globulin
solution
blood
process according
precipitated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA242,734A
Other languages
English (en)
Inventor
Dietrich Wolter
Waldemar Schneider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Plasmesco AG
Original Assignee
Plasmesco AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plasmesco AG filed Critical Plasmesco AG
Application granted granted Critical
Publication of CA1058075A publication Critical patent/CA1058075A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA242,734A 1975-01-02 1975-12-30 Procede pour ameliorer la compatibilite des gamma globulines Expired CA1058075A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2500076A DE2500076C3 (de) 1975-01-02 1975-01-02 Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen

Publications (1)

Publication Number Publication Date
CA1058075A true CA1058075A (fr) 1979-07-10

Family

ID=5935911

Family Applications (1)

Application Number Title Priority Date Filing Date
CA242,734A Expired CA1058075A (fr) 1975-01-02 1975-12-30 Procede pour ameliorer la compatibilite des gamma globulines

Country Status (20)

Country Link
JP (1) JPS5512001B2 (fr)
AT (1) AT344883B (fr)
AU (1) AU505416B2 (fr)
BE (1) BE837211A (fr)
CA (1) CA1058075A (fr)
DD (1) DD121875A5 (fr)
DE (1) DE2500076C3 (fr)
DK (1) DK144679C (fr)
EG (1) EG11987A (fr)
ES (1) ES443982A1 (fr)
FR (1) FR2296429A1 (fr)
GB (1) GB1495159A (fr)
IE (1) IE43449B1 (fr)
IL (1) IL48766A (fr)
IN (1) IN143525B (fr)
NL (1) NL179824C (fr)
PL (1) PL99599B1 (fr)
SE (1) SE437470B (fr)
SU (1) SU576898A3 (fr)
ZA (1) ZA758050B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2604759C2 (de) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von iv-verträglichen Γglobulinen
JPS6016406B2 (ja) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
GB1603244A (en) * 1977-05-20 1981-11-18 Max Planck Gesellschaft Medicaments for the suppression of pathological processes
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
EP0019403B1 (fr) * 1979-05-10 1985-07-31 American Hospital Supply Corporation Support de médicament en hydroxyalkylamidon
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
ATE19735T1 (de) * 1982-02-08 1986-05-15 Schweiz Serum & Impfinst Intravenoes verabreichbares humanes immunglobulin und verfahren zu dessen herstellung.
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
SE8302483L (sv) * 1983-05-02 1984-11-03 Pharmacia Ind Forfarande vid rening av biologiskt aktiva substanser
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
DE19907257A1 (de) * 1999-02-21 2000-09-14 Bernd Horst Meier Mittel zur Steuerung der Diffusion von Injektionslösungen
DE10040707A1 (de) * 2000-08-17 2002-03-14 Braun Melsungen Ag Kolloidale Pharmakomodulation injizierter Arzneimittel
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
PT1954718E (pt) 2005-11-30 2014-12-16 Abbvie Inc Anticorpos anti-globulómeros aβ, suas porções de ligação ao antigénio, correspondentes hibridomas, ácidos nucleicos, vectores, células hospedeiras, métodos de produção dos ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos para uso dos ditos anticorpos
KR20180058863A (ko) 2005-11-30 2018-06-01 애브비 인코포레이티드 아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US20100311767A1 (en) 2007-02-27 2010-12-09 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
MX336196B (es) 2010-04-15 2016-01-11 Abbvie Inc Proteinas de union a amiloide beta.
EP3533803B1 (fr) 2010-08-14 2021-10-27 AbbVie Inc. Anticorps anti-bêta-amyloïde

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE348942B (fr) * 1970-06-02 1972-09-18 Statens Bakteriologiska Labor
DE2234069A1 (de) * 1971-07-16 1973-02-08 South African Inventions Verfahren zur herstellung eines gereinigten gamma-globulins
IL43643A (en) * 1972-11-27 1976-10-31 Baxter Laboratories Inc Method for production of gamma globulin
JPS49101516A (fr) * 1973-01-13 1974-09-25

Also Published As

Publication number Publication date
SE437470B (sv) 1985-03-04
FR2296429B1 (fr) 1978-12-01
DE2500076C3 (de) 1982-11-18
IL48766A (en) 1979-11-30
FR2296429A1 (fr) 1976-07-30
AU505416B2 (en) 1979-11-22
IE43449B1 (en) 1981-02-25
IE43449L (en) 1976-07-02
NL179824C (nl) 1986-11-17
DD121875A5 (fr) 1976-09-05
ES443982A1 (es) 1977-07-16
ATA981675A (de) 1977-12-15
ZA758050B (en) 1976-12-29
IN143525B (fr) 1977-12-17
DK584375A (da) 1976-07-03
SE7514388L (sv) 1976-07-05
DK144679C (da) 1982-10-11
JPS5512001B2 (en) 1980-03-29
DE2500076B2 (de) 1979-02-22
EG11987A (en) 1981-12-31
GB1495159A (en) 1977-12-14
AU8792175A (en) 1977-07-14
NL179824B (nl) 1986-06-16
IL48766A0 (en) 1976-02-29
DE2500076A1 (de) 1976-07-08
PL99599B1 (pl) 1978-07-31
AT344883B (de) 1978-08-10
BE837211A (fr) 1976-06-30
JPS5191321A (en) 1976-08-10
SU576898A3 (ru) 1977-10-15
NL7514627A (nl) 1976-07-06
DK144679B (da) 1982-05-10

Similar Documents

Publication Publication Date Title
CA1058075A (fr) Procede pour ameliorer la compatibilite des gamma globulines
CA1074698A (fr) Methode pour augmenter la production de facteur antihemophilique viii dans le sang et le plasma
US5177194A (en) Process for purifying immune serum globulins
US4216205A (en) Process of preparing a serum protein composition for intravenous application
US4069216A (en) Simplified methods for preparation of very high purity Factor VIII concentrate
CA1083959A (fr) Procede de production d'une immunoglobuline intraveineuse
KR960001473B1 (ko) 정맥 주사용 면역글로불린 제제의 제조 방법
US4764279A (en) Process for preparing the principal proteins of hemolyzed blood in the non-denatured form
EP0011032B1 (fr) Procédé d'isolation de HBsAg
US4164495A (en) Method of recovering immunoglobulin using a polyol and an alkanoic acid
CA1323139C (fr) Methode servant a la production d'albumine en grande partie pure
SK54993A3 (en) Imidoester cross-linked hemoglobin compositions
US4322403A (en) Method for the preparation of an immune globulin solution suitable for intravenous use
Zittle et al. Purification of human red cell acetylcholinesterase
USRE31268E (en) Method of recovering immunoglobulin using a polyol and an alkanoic acid
EP0138167A1 (fr) Méthode de purification d'HBs antigène
JPS62503036A (ja) 静脈を介して投与されるガンマ−グロブリンの調製方法および該方法により得られたガンマ−グロブリン
CA2040036A1 (fr) Serum-albumine humaine normale essentiellement monomerique
GB2146027A (en) Process for producing human interferon and method for assaying the interferon productivity of blood
US4197238A (en) Method of preparation of human albumin using polyethylene glycol
Masri et al. Studies on abnormal hemoglobins. XII. Terminal and free amino groups of various types of human hemoglobin
US3745155A (en) Purifying a gamma globulin by contacting a solution of gamma globulin with solid plasma protein free of gamma globulin
Sakami et al. Purification of folic acid
US2123198A (en) Treatment of antitoxins and the like
US3203865A (en) Hog serum antibody concentrate